Codexis, Inc. Hits New 52-Week Low at $0.96 Amid Financial Struggles

Codexis, Inc., a microcap company in the specialty chemicals industry, has reached a new 52-week low of USD 0.96 as of March 4, 2026. This significant decline reflects a challenging year for the company, which has seen its stock price plummet by 67.07% over the past year, contrasting sharply with the S&P 500's performance of 17.36% during the same period. The company's financial metrics indicate ongoing difficulties, with negative results reported for the last four consecutive quarters. Operating cash flow has reached a low of USD -55.94 million, while net sales have fallen by 39.82% to USD 8.6 million. Additionally, Codexis has a return on equity of -158.13%, highlighting the challenges it faces in generating profits. With a market capitalization of USD 106 million, Codexis is navigating a precarious financial landscape, characterized by a debt-to-equity ratio of -0.42 and a price-to-book ratio of 2.74. The stock's performance has consistently underperformed against the S&P 500 over the last three years, raising concerns about its long-term growth prospects.